INTRODUCTION
While next generation sequencing (NGS) has accelerated the discovery of new functional variants 43 in syndromic and rare monogenic diseases, many more disease-causing genes and novel genetic etiologies absent from gnomAD, versus un-constrained variants as being those with exon minor allele frequency 146 (MAF) > 0, a strategy similar to that employed by other groups [52, 53] .
148
Global constraint to maintain stability 149 Our study reveals a striking connection between a given SNV's impact on mRNA structure and its 150 frequency in the gnomAD database. We define the central variable Y to be Y=1 when a SNV is present 151 in gnomAD and Y=0 when the SNV is absent. We hypothesize that variants which disrupt mRNA 152 structure should have Y=0 (i.e. be absent from the gnomAD database), while those with limited impact 153 on structure should tend to have Y=1 (i.e. appear at least once in the gnomAD database).
154
This central hypothesis is validated in FIGURE 3, which depicts the proportion of SNVs with Y=1 155 at every value of our stability-metric dMFE. All four variant classifications -synonymous, 5 prime UTR, 156 3 prime UTR and missense -show a bi-directional constraint to maintain the wild-type mRNA structure.
FIGURE 4B
shows an analogous plot for the structural disruption metric CFEED (see 169 SUPPLEMENTARY FIGURE 2 for an illustration of how CFEED is calculated). This plot appears to depict 170 two separate trends, but actually shows a single pattern that alternates between high and low on successive 171 values: the sSNVs with CFEED=0, 4, 8, 12.. . are enriched over those with CFEED=2, 6, 10, 14... (CFEED 172 can only take on even values because the destruction/creation of a base pair always requires two edits). 173 One possible explanation for this duality is that when CFEED fails to be divisible by 4, there is necessarily 174 a change in the total number of base-pairings in the mRNA centroid structure. Thus, sSNVs which 175 conserve the total number of base-pairs could be potentially favored. FIGURE 4B also supports the 176 hypothesis that structurally disruptive sSNVs should appear less frequently in the population. We see that 177 sSNVs which leave the centroid structure unchanged (i.e. CFEED=0) are roughly 15% more common 178 than those sSNVs predicted to alter it. And within each of the two separate trends (that is, the multiples 179 and non-multiples of 4) the population frequency declines as the number of centroid base-pairing changes 180 grows from small to large. 181 Finally, sSNVs which either diversify the ensemble of mRNA structures (high dCD) or 182 homogenize it (low dCD) are depleted in the population proportionately to their disruptions, as shown in 183 FIGURE 4C. The symmetry in depletion between over-and under-diversifying sSNVs is surprisingly 184 regular. (Here and throughout, dCD values are rounded to the nearest integer, a step necessitated by the 185 fact that the dCD metric does not cluster into just a few values like the other two.) 186 The relationship between the three metrics is illuminated by color-coding in FIGURE 4. We observe 187 in FIGURES 4A AND 4B that disruptions in the magnitude of stability (|dMFE|) and base-pairing (CFEED) 188 of a sSNV are markedly correlated, with the two metrics enriched for each other at extreme values (red 189 coloring). FIGURE 4C depicts a clear relationship between diversity and stability, with those sSNVs 190 diversifying the ensemble (high dCD) also tending to de-stabilize it (red) . This diversity-instability 191 relationship is intuitive, as a destabilizing mutation "frees up" portions of the mRNA to assume new forms. 192 Together, these observations validate the central hypothesis that sSNVs which disrupt mRNA structure 193 should be constrained in human populations. 194 195 Variation of constraint with REF>ALT context 196 An mRNA's secondary structure is largely determined by its primary structure (i.e. by the 197 sequence of nucleotides). We therefore expect the constraint in FIGURE 4 to be partially mediated by 198 the sequence features around each sSNV, the most immediate of which are its reference and alternate 199 bases. Accordingly we divide our sSNVs into 14 classes (TABLE 1) : 12 classes based on their reference 200 and alternate alleles (e.g. A>C, C>G, T>C, etc.) and 2 additional classes based on potential loss of 201 methylated cytosine (CpG>TpG or CpG>CpA, the latter of which results from a deamination on an 202 antisense strand). Then within each REF>ALT context we reconstruct the three plots of FIGURE 4 and 203 also perform weighted linear and quadratic regressions between the three different stability metrics and 204 Y=1 (see METHODS for details). All significant results (p < 0.005) of this procedure appear in TABLE 205 1. 206 Looking at TABLE 1A (which shows the results for dMFE) we find that disruptions to mRNA 207 stability are constrained across many of our sSNV classes. The fact that most of linear p-values are much 208 smaller than the quadratic p-values indicates that in most contexts the dMFE-Y relationship is linear, in 209 contrast to the bell-shaped relationship we see when considering global dMFE (FIGURE 4A). Therefore, 210 the slope of the regression line indicates which direction of dMFE is enriched for Y=1. For example, in 211 the context of G>T the negative normalized slope indicates that lower dMFE values (i.e. stabilizing) are 212 less constrained (i.e. Y=1). The slope of the regression line (and the relationships it models) proves to 213 depend largely on whether a context's REF and ALT nucleotides are "strong" (C,G) or "weak" (A,T) 214 binders. We note from TABLE 1A that strong>weak mutations consistently have negative slopes (except 215 in the irregular context G>A; see Constraint for mRNA stability in non-CpG-transitional contexts), while 216 the two weak>strong contexts A>G and T>C have positive slopes.
217
In TABLE 1B we observe the constraint for the structural disruption metric CFEED. The results 218 here are surprising -the contexts are split between positive and negative slopes. In support of our 219 hypothesis, four of the sequence contexts display a negative slope, implying that sSNVs with high CFEED 220 values are constrained. However, in contrast to our hypothesis, three of the sequence contexts have a 221 positive slope, which implies that sSNVs in these contexts with high CFEED values are enriched. In the 222 case of CpG>TpG mutations the low quadratic p-value indicates that the pattern is actually bell-shaped, 223 with both low and high CFEED values being depleted; but in G>A and C>A contexts the quadratic term 224 is not significant. Actual plots of these patterns reveal that the ones in which CFEED is depleted are more 225 striking (see FIGURE 5 and SUPPLEMENTARY FIGURES 4-5 for plots of Y vs. CFEED in all stability-226 significant contexts), but this unexpected result must still be addressed. We speak more on this topic in 227 the DISCUSSION. 228 Finally, TABLE 1C shows mutation contexts that are significantly constrained against changes to 229 ensemble diversity. We see that only a few contexts experience this constraint. But when significant, the 230 constraint for diversity appears to inherit the bidirectionality of FIGURE 4C (with the quadratic term being 231 the most significant and the linear fit being very poor). In these contexts, decreases and increases to 232 ensemble diversity appear to be equally harmful. 235 The data in TABLE 1 highlight that our observed constraint for mRNA structure is the greatest 236 when considering CpG transitions. Since these variants (and their suppression) are crucial to the story of 237 mRNA stability, it is important to have an appreciation of their role in a biochemical context. The 238 dinucleotide CG (usually denoted CpG to distinguish this linear sequence from the CG base-pairing of 239 cytosine and guanine) is capable of becoming methylated and then mutating by a process called 240 "deamination" into a TG dinucleotide. While studies have demonstrated that methylated CpG residues are 241 up to 40X times more likely to be deaminated than their unmethylated counterparts [54], mechanisms 242 exist to enzymatically repair CpG deaminations [55, 56] . In mammals 70-80% of CpGs are methylated, 243 which makes a CpG transition almost 5x more common than any other mutation-type among mammals 244 (see SUPPLEMENTARY DATA 
234

CpG transitions have constraint against de-stabilization of their mRNA structures
247
The nucleotides C and G also form the foundation of mRNA secondary structures. Most of the 248 energy of an mRNA structure lies in its "stacks" of nucleotides with the average energy of a C-G pair in 249 a stack around 65% stronger than that of any other base-pairing [59] . Moreover, the self-complementarity 250 of CpGs means that upstream and downstream instances can bind together and form a four-base stack 251 which other base-pairs can then build around.
252
In the present study we find strong evidence that CpG transitions are constrained against de-253 stabilization of their mRNA structures. This striking trend is largely explained (in a statistical sense) by 254 CpG content, i.e. number of CpG dinucleotides in the surrounding 120 nucleotides of the mRNA transcript 255 (see "Depleter" R 2 in TABLE 1). We distinguish CpG>CpA versus CpG>TpG transitions (the former of 256 these usually results from a CpG>TpG deamination on an anti-sense DNA strand), as these two mutation-257 types show a qualitatively different constraint for mRNA structure. FIGURE 5 shows the performance of 258 our three main metrics in CpG-transitional contexts. Most strikingly, we find that synonymous CpG>CpA 259 and CpG>TpG mutations both show a steady constraint against de-stabilization (high dMFE) (FIGURES 260 5A & 5B). Fascinatingly, both contexts exhibit a cluster of outliers in the most destructive (i.e. most de-261 stabilizing region), suggestive of extreme constraint borne of significant structural disruption. Though the 262 two plots exhibit the same basic shape, the context CpG>CpA of FIGURE 5A shows higher de-stabilizing 263 tendencies (higher dMFE values) and also a stronger constraint (lower P(Y=1)).
264
The behavior of the edge metric CFEED in these contexts is less clear-cut. In FIGURE 5C we see 265 a clear pattern of constraint against mutations with high CFEED values; and the red coloring shows that 266 such changes are, on average, de-stabilizing. But the constraint in the context CpG>TpG (FIGURE 5D) is 267 much less forceful (in fact, its quadratic p-value is much smaller than its linear) and the blue coloring by 268 dMFE shows such mutations are on average neutral or even de-stabilizing. Finally, FIGURES 5E & 5F 269 show that the basic pattern of constraint for diversity in FIGURE 4C is reproduced and is essentially 270 unchanged for both types of CpG transition. The coloring again indicates that mutations CpG>CpA are 271 much more destabilizing than their CpG>TpG counterparts.
272
The markedly greater constraint and tendency towards de-stabilization among CpG>CpA 273 transitions suggests they are under different selective pressures than CpG>TpG transitions, despite being 274 largely produced by the same biochemical mechanism (a CpG>TpG deamination on either a positive-or 275 negative-sense strand -see SUPPLEMENTARY DATA 279 We see the strongest constraint for mRNA structure in CpG transitions, but we observe an 280 analogous pattern in most REF>ALT contexts (as indicated by TABLE 1). We can classify these remaining contexts the data are consistent with the hypothesis that sSNVs which de-stabilize mRNA are constrained.
Constraint for mRNA stability in non-CpG-transitional contexts
284
Notably, all these contexts are strong>weak (or strong>strong in the case of C>G), consistent with the 285 principle that one purpose of such nucleotides is to maintain stability. The coloring by CFEED indicates 286 that a change in either direction is likely to alter the mRNA secondary structures.
287
In SUPPLEMENTARY FIGURE 5 we show the contexts where dMFE and Y vary positively, which 288 amounts to the claim that stabilizing mutations are constrained in these contexts. Correspondingly, we 289 note that two out of three of these contexts are weak>strong (and the third is the unusual context G>A 290 where SNPs that alter stability or diversity are actually enriched). The context T>C exhibits a notable 291 constraint in either direction, an anomaly which we speculate on in the DISCUSSION.
293
Depleter variables 294 In TABLE 1 we provide a "Depleter" for the connection between our RNA folding metrics and 295 gnomAD frequencies for each mutational context. The name "Depleter" signifies that each such variable 296 is chosen so as to correlate negatively with gnomAD (which is why these variables are given with +/-297 signs in TABLE 1). For example, the Depleter for dMFE in the context CpG>CpA is +CpG content, 298 meaning that when CpG content increases in this context, the varaible Y is depleted.
299
The Depleter is chosen to be the variable that best explains the connection between the mRNA 300 structural variable and Y in the given context. The proportion of connection explained is given by the field 301 "Depleter R 2 ". For example, in the context CpG>CpA we can explain 78% of the dMFE-gnomAD 302 connection using a model that relies only CpG content.
303
To determine which variable is most informative (and should therefore be called the Depleter) we 304 compute an associated R 2 for a set of features of the sequence around the sSNV (the upstream/downstream 305 nucleotides and the proportion of A, C, G, T, CpG or ApT [di]nucleotides in the surrounding 120 bases).
306
Each of these features is used to build a simple logistic model to predict Y=1, and the predictions of the 307 model are then compared to the actual proportion P(Y=1) at a value of the metric. For example, building 308 a CpG-context-based model allows us to compute the quantity P(Y=1 | CpG content), and then we consider 309 the difference:
Squaring this difference and taking a weighted sum over all values of dMFE in a context, we recover the 312 variance left unexplained by a particular non-structural variable. We obtain an R 2 by comparing 313 unexplained variance to that obtained using a null model, and the Depleter is then the variable with the 314 largest R 2 (see METHODS for more details). TABLE 1 shows that Depleters can recover large portions of 315 the trends in FIGURE 5 and SUPPLEMENTARY FIGURES 4-5. The striking trend between dMFE and 316 gnomAD frequency in CpG-transitional contexts is largely driven by the proportion of CpGs in the 317 surrounding 120 nucleotides (73% for CpG>TpG sSNVs and 79% for CpG>CpA sSNVs). CpG content 318 is also the most powerful feature when accounting for the behavior of CFEED and dCD in these contexts, 319 with high CpG content consistently correlating with depletion. The natural inference is that an abundance 320 of CpGs signifies important mRNA structure nearby, the disruption of which could be deleterious.
321
In non-CpG-transitional contexts, the Depleter almost always proves to be a nucleotide upstream 322 or downstream of the sSNV. In the context C>A we can recover 28% of the relationship between dMFE 323 and gnomAD frequency simply by looking at whether the C is followed by a G. The power of CpG 324 dinucleotides in recovering our structural trends in the contexts C>A, C>G, G>C and then G>T, 325 emphasizes the powerful but poorly understood role of CpGs in both mRNA stability and mammalian 326 genomes.
328
Global quantification of mRNA constraint 329 Our analysis shows that variants predicted to influence mRNA secondary structures are 330 constrained in the population. However, due to the multiple facets that need to be considered when 331 studying RNA secondary structure, by focusing on a single RNA-folding metric such as dMFE or CFEED, 332 we run the risk of missing functionally relevant information. To overcome this potential limitation of our 333 RNA folding metrics, we set out to devise a more diversified method for predicting possible pathogenicity 334 due to mRNA structure. Our strategy is to consider the additional statistical power bestowed by mRNA 335 structure. In each of our 14 sequence contexts from TABLE 1 we build two general logistic models for 336 predicting MAF >0: a null model that uses the natural variables of sequence context, local nucleotide 337 composition, transcript position and tRNA propensity, but NOT mRNA structure (n); and a structural 338 model which also includes the 10 metrics obtained from our ViennaRNA analysis (s). These models yield 339 two separate probability-predictions Pn and Ps for the quantity P(MAF >0) (see METHODS for details).
340
Then we define the metric:
The metric SPI thus measures the additional predictive power bestowed by mRNA-structural 343 variables. When it varies from 0, mRNA structural predictions yield new insight about a SNV's potential 344 to have a functional role in mRNA secondary structure. The power of SPI in each context (given by its 345 area under the curve in predicting whether gnomAD is >0) is supplied in TABLE 2 and we plot SPI vs. Y structural metrics as each shows a value of |dMFE|, CFEED, |dCD| or |SPI| that is in at least the 80 th 360 percentile in its context. For example, the pathogenic sSNV in NKX2-5, linked to congenital heart disease, 361 has a dCD score in the 90 th percentile [44] . It should be noted that none of these clinical sSNVs qualify as 362 truly exceptional outliers for any of our ViennaRNA metrics or SPI; all have scores below the 95 th 363 percentile for |dMFE|, CFEED, |dCD| or |SPI| (see DISCUSSION for suggested score cutoff values). 364 365 DISCUSSION 366 We have shown that in silico mRNA structural predictions can be used to predict and explain the 367 population allele frequency of a synonymous variant. By calculating ViennaRNA folding metrics for 368 nearly 0.5 billion possible SNVs, we demonstrate that there is significant selection against sSNVs 369 predicted to either stabilize or de-stabilize the given transcript's local mRNA secondary structure. While 370 the observed trends can be partially explained by sequence-based variables like CpG or GC content or 371 membership in a CpG/AT/TA dinucleotide (as given by the "Depleter" field in TABLE 1), we believe our 372 data support our hypothesis that RNA structure itself plays a critical role in human health and disease. As 373 such, polymorphisms impacting mRNA structure are under negative selection in the population and should 374 be more carefully evaluated in the context of both Mendelian disorders and complex human disease.
375
When determining if the connection between mRNA disruption and population incidence is direct 376 and causal, we need to consider three factors. First, constraint of mRNA structure must be exercised 377 through sequence-based variables, since the underlying primary mRNA sequence largely determines the 378 secondary structure. Thus, although the trends we have observed may be influenced by sequence features 379 such as CpG content (as illustrated by the "Depleter" variable in TABLE 1), it does not necessarily indicate 380 that the trends are spurious. Second, it is important to note that our trends operate in the directions implied 381 by our hypothesis: sSNVs that disrupt mRNA (measured three different ways) are depleted rather than 382 enriched in the population for almost all REF>ALT contexts. Third, mutations that are predicted to change 383 stronger base pairs to weaker ones are consistently constrained against de-stabilization rather than over-384 stabilization. If the association were spurious, we would not expect such agreement with prediction.
385
Our data also include some patterns which can be elegantly explained through mRNA structure. Finally, in addition to the metrics output by our ViennaRNA analysis, we devised our own metric 397 to measure structural pathogenicity. The Structural Predictivity Index (SPI), created specifically to control 398 for all confounding factors, shows that mRNA structure has predictive power all by itself. Also, the 399 clusters of outliers at the extreme values of our structural metrics (see FIGURES 5 and SUPPLEMENTARY 400 FIGURES 4,5) suggest a constraint beyond that explained by any confounding variable.
401
Taken together, this evidence provides significant support for the hypothesis that disruptions to 402 mRNA structure are directly under constraint. However, we also realize there are other molecular 403 mechanisms at work in the regulation of the transcriptional and translational processes. For example, while 404 the retention of CpG dinucleotides is certainly connected to mRNA structure, other factors such as 405 regulatory methylation, tRNA binding, binding of miRNAs and other RNA binding proteins, DNA 406 chromatin structure and epigenetic modifications in the ORF could also be involved. Relatedly, we found 407 a few contexts where sSNVs which disrupt mRNA structure actually have higher population frequencies 408 than those that do not (TABLE 1), the main example being the enrichment of high CFEED values in the 409 contexts C>A and G>A. In both cases, the Depleter variable is a trailing A, which correlates negatively 410 with gnomAD frequency and CFEED. The presence of an A is likely to have minimal effect on mRNA 411 structure, suggesting that in these contexts the connection is partly spurious. ). These tools predict whether a nsSNV is pathogenic or benign, primarily 431 due to the high conservation of protein sequences. However, these algorithms are not equipped to assess 432 pathogenicity in synonymous variants, which are under different constraints [11] . Recognizing that there 433 is a critical need for methods that better predict the potential whether sSNVs have pathogenic impact and 434 function, our goal in this present study was the generation of such metrics. ViennaRNA stability and SPI 435 metrics are available for download for all known sSNVs, to enable researchers and clinicians to evaluate 436 WES and WGS data in combination with tools such as Annovar [71], SnpEff [72] and VEP [73] .
437
The role of synonymous mutations in human disease is gaining recognition in the community. The
438
RNAsnp Web Server predicts the change in optimal mRNA structure and base-pairing probabilities due 439 to a SNV [74] . A command line tool called remuRNA calculates the relative entropy between the mutant 440 and wildtype mRNA structural ensembles [75] . While these tools predict disruptions to mRNA structure, 441 they do not attempt to predict pathogenicity and must be executed manually on each variant of interest. structure, most of these cases lacked functional studies to conclusively implicate the given variant in 451 disease. As such we focused on a set of six sSNVs that we believe the authors unequivocally demonstrated 452 to be pathogenic through their effects on mRNA structure ( All six sSNVs demonstrated definite enrichment for our structural metrics, by stability, edge 457 distance, diversity or SPI, with values in the 80 th to 90 th percentile range. However, none of these clinically 458 relevant sSNVs qualifies as a truly exceptional outlier for any of our ViennaRNA metrics or SPI with all 459 percentiles being below 90. It is theoretically possible that such extreme outliers are not biologically 460 tenable, making them less likely to appear in the human population. As such, a change in the 80 th percentile 461 could represent a cutoff for biological significance. Another possibility (perhaps equally strong) is that 462 these sSNVs occupy important regulatory positions, and that a sSNV deleterious to mRNA secondary 463 structure may exhibit pathogenicity when it distorts structure in a key region of the transcript.
464
The enrichment of our structural metrics, while moderate, is still clear and our hope is that future 465 studies will allow refinement and enhancement of our metrics. As new discoveries of pathogenic sSNVs 466 in human genetic disease occur, a larger data set of known clinically relevant sSNVs will help determine 467 cutoff values. For now, our recommendation is that a conservative 80 th percentile cutoff across the four 468 metrics is used initially, but this may need to be lowered to reveal pathogenic sSNVs that have a less 469 extreme change to mRNA structure. 472 Synonymous variants that impact mRNA secondary structure could confer pathogenicity in 473 numerous ways. For example, sSNVs can alter global RNA stability, where less stable RNA molecules 474 may be degraded more quickly resulting in lower protein levels [23, 25, 27] . As local RNA structure is 475 essential for the translation process, a more stable mRNA may not be able to initiate translation, also 476 resulting in lower protein levels [20, 21, 30, 31] . Additionally, numerous studies argue that by making the 477 mRNA structure too difficult, or too easy, for the ribosome to process, synonymous codons may act as a 478 subliminal code for protein folding [16, 30, 32, 33, 35] .
Molecular mechanisms underlying constraint of sSNVs
479
While there is a large body of literature supporting the essential role of sSNVs in preservation of 480 mRNA secondary, sSNVs also play roles in other molecular processes that could impact our observations.
481
While the stability of an mRNA transcript can determine how quickly it is translated [19, 29, 30] , protein 482 synthesis is also regulated by both the abundance [78] and recruitment of tRNAs through synonymous 483 codon utilization (codon bias) [79] [80] [81] . Changes in the bicodon bias has the potential to lead to 484 pathogenicity of synonymous mutations in human disease [16, 35] . As such, this may have had a 485 confounding impact on our analysis of constraint, but we attempted to mitigate this by including the tRNA 486 Adaptivity Index (a measure of tRNA abundance) in our set of confounding variables.
487
Some of our constraint might have its roots in the tertiary DNA structure, where DNA bending 488 plays roles in DNA packaging, transcriptional regulation, and specificity in DNA-protein recognition 489 [82]. While it has been suggested that synonymous codon choice may play a role in DNA bending [83] , 490 the process is largely governed by intergenic and intronic DNA, and as such is unlikely to be directly 491 responsible for the constraint shown in FIGURE 2. We attempted to mitigate the role of local DNA 492 sequence context and CpG content, by including both in our set of confounding variables when generating 493 SPI. However, methylation of CpG dinucleotides can regulate gene expression, potentially making it 494 difficult to state whether selection for mRNA structure causes the retention of CpGs, or whether the 495 retention of CpGs is regulated by a process independent of mRNA structure. A strong reason for CpGs to 496 operate causally with regard to mRNA structure is that they are the most important determinant of mRNA Finally, it is important to also consider the essential role that synonymous variants play in RNA 503 splicing. While we took care to exclude sSNVs impacting the canonical splice sites from our constraint 504 analysis, exonic variants beyond the canonical splice site can disrupt splice enhancers [85], or they may 505 also activate cryptic splice sites, leading to aberrant pre-mRNA splicing and loss of coding sequence [86] .
506
Given the diversity of molecular roles that synonymous codons have, it will be important for future studies 507 to create scores that would allow assessment of sSNV pathogenicity through any these possible 508 mechanisms. 509 510 CONCLUSIONS 511 We have shown that sSNVs which stabilize or destabilize mRNA are significantly constrained in 512 the human population, thereby supporting a growing body of evidence that previously assumed "silent" 513 polymorphisms actually play crucial roles in regulation of gene expression and protein function. We have 514 demonstrated that this connection is rich, complex, and biologically intuitive. Given that there are multiple 515 mechanisms by which sSNVs influence biological function, we are almost certainly missing undiscovered 516 disease etiologies when these variants are ignored. In addition to providing the community with a dataset 517 of ten ViennaRNA structural metrics for every known synonymous variant, our Structural Predictivity 518 Index is the first metric of its kind to enable global assessment of sSNVs in human genetic studies. We 519 hope that these metrics will be utilized to accurately assess and prioritize an underrepresented class of 520 genetic variation that may be playing significant and as yet to be realized role in human health and disease. Overview of RNA structure prediction process 529 To estimate the structural properties of a sSNVs we used the ViennaRNA software package, a 530 secondary structure prediction package that has been extensively utilized and continuously developed for in the human genome (about 500,000,000 calculations) was a computationally challenging task which we 534 carried out using an Apache Spark framework powered by Amazon Web Services (AWS). We built a 535 pipeline which read in and analyzed a SNV and stored the results in AWS Simple Storage Service (S3) in 536 Parquet columnar file format (FIGURE 2) . The ease and capacity of AWS greatly facilitated the project, 537 and the affordability of S3 storage means our data can easily be shared with others. The software we 538 developed is available on GitHub: https://github.com/nch-igm/rna-stability. 539 540 RNA structure prediction methodology 541 To analyze a given SNV we built a 101-base sequence consisting of a central nucleotide at the 51st 542 position (which we set to either the reference or the three alternates) along with the 50 flanking bases on 543 either side. If the nucleotide lay 50 bases from the transcript boundary, the window was simply taken to 544 be the first or last 101 bases in the transcript. We processed these sequences in fasta format with 545 ViennaRNA's flagship module RNAfold, which yielded three predicted mRNA secondary structures -546 the minimum free energy, centroid, and maximum expected accuracy structure -as well as numeric values 547 for the free energy of each structure, and a fourth metric measuring the energy of the whole ensemble (see 548 the documentation of [18] for detailed descriptions of these concepts). Comparing the free energies 549 between the wildtype and mutant for each type of structure gave us the four stability metrics delta-MFE 550 (dMFE), dCFE, dMEAFE and dEFE. Next, the predicted structures were processed by the ViennaRNA 551 module RNApdist, which counted the edge-differences to produce the four edge-metrics MFEED 552 (minimum free energy edit distance), CFEED, MEAED and EFEED. As a final step, the predicted 553 structures were further processed by the ViennaRNA program RNAdistance to obtain the diversity metrics 554 dCD and dEND (change in distance from centroid and change in ensemble diversity, respectively).
555
This whole procedure was carried out using custom developed Spark wrappers of RNAfold,
556
RNApdist and RNAdistance, with slight modifications to the source code to suppress the creation of 557 graphics files. After building our fasta files, we were able to compute all 10 ViennaRNA metrics for over 558 a half billion sequences in less than 24 hours using 51 c4.8xlarge AWS EMR computing nodes.
560
Construction of final dataset for synonymous SNVs 561
The next step was to extract the sSNVs. This task was complicated by the fact that a SNV might 562 have appeared in several different transcripts, and could be synonymous in some and non-synonymous in 563 others. To address this challenge, we first annotated every SNV using the program snpEff [72], whose 564 source code was modified to allow record-by-record calling via Spark. This snpEff analysis produced 565 annotations of predicted biotype, e.g. missense, synonymous, canonical splice site, etc. To validate these 566 snpEff predictions we manually predicted the biotype of each SNV using start and stop codon information 567 from RefSeq (ftp://ftp.ncbi.nih.gov/refseq/H_sapiens/RefSeqGene/refseqgene.*.genomic.gbff.gz). The 568 small number of sSNVs where our predicted biotype disagreed with snpEff's were discarded. We then 569 defined a "synonymous SNV" to be one that was (A) synonymous in at least one transcript, (B) 570 synonymous or within the UTRs in all transcripts, and (C) not implicated in splicing by snpEff. Each 571 sSNV identified as "synonymous" by this scheme was assigned a "home transcript," chosen based on 572 proximity to the start codon, then on maximal transcript coding sequence length, and then arbitrarily. 578 To measure constraint operating on a sSNV we used population frequencies obtained from the 579 gnomAD database. Since this resource only existed for the GRCh37 reference build, we lifted our entire 580 dataset from GRCH38 to GRCh37. The lifting procedure was carried out using the Picard Tools program 581 liftOver [88], which was executed using a custom Spark wrapper. The joining of the gnomAD frequencies 582 to our main dataset was a task greatly facilitated by Spark's parallel processing and native Parquet support.
Merging of sSNV GRCh38 transcript coordinates with gnomAD GRCh37 coordinates
583
Since the great majority (approximately 90%) of sSNVs were marked with gnomAD frequency 0, it is 584 important to identify sSNVs marked zero purely through a lack of coverage. To achieve this, we flagged 585 and removed all sSNVs where fewer than 70% of samples had at least 20X coverage. 595 We carried out most of the analysis separately on subsets of data defined by a common mRNA 596 reference and alternate allele, e.g those sSNVs of form C>A. The reference and alternate alleles exert such 597 a huge influence on gnomAD frequency that the best solution seemed to be to control for them explicitly.
Partition of dataset
598
Dividing our dataset based on mRNA alleles (as opposed to DNA alleles, which do not depend on 599 transcript sense) is a step justified in SUPPLEMENTARY TABLE 3.
601
Depleter variables 602 Depleter variables (so called because they explain some of the gnomAD depletion at values of a 603 structural variable) are given in TABLE 1. They are chosen to be the sequence feature that explains the 604 greatest portion of the connection between a structural metric (e.g. dMFE) and Y in a context. Possible
605
Depleter variables are local nucleotide content and the specific nucleotides up/downstream of the sSNV.
606
To compute the correlation between a structural metric (e.g. dMFE) and Y that is left unexplained 607 by a sequence feature (e.g. CpG content) in a particular REF-ALT context, we first build a simple logistic 608 regression model between CpG content and Y, which gives us an estimate (Y = 1 | CpG content ) for 609 every sSNV in the context (based on the proportion of CpGs in the surrounding 120 nucleotides). We then 610 plug this "structure-less" estimate into the expression The "Depleter" for a given structural metric in a given context is chosen as the variable with the 618 highest R 2 . Finally the correlation between the Depleter and Y was checked, and the Depleter given a sign 619 (+/-) so that the signed Depleter correlated negatively with Y. 10 ViennaRNA metrics. Both sets of variables were then used to predict MAF > 0. We then defined the 629 SPI score for a sSNV to be the base-10 logarithm of the active model's predicted P(Y=1) probability 630 divided by the null model's predicted P(Y=1). Context wise plots for SPI are given in the 631 SUPPLEMENTARY FIGURE 6. 632 We tried three different model-styles for computing the raw predictions that comprise SPI - Availability of data and materials: 647 The software we developed and structural scores are available on GitHub: https://github.com/nch-648 igm/rna-stability.
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